TEST DESCRIPTION:
The detection of adenovirus DNA is based upon the real-tlme amplification and detection of conserved adenovirus genomic DNA sequences through Real-Time Polymerase Chain Reaction (PCR) and qualitative PCR.

TEST DESCRIPTION:
Alanine Aminotransferase (Al.T) test measures the amount of the Al.T enzyme in the blood via spectrophotometry. The measurements for Al.T are particularly useful in the diagnosis and management of certain liver diseases such as viral hepatitis and cirrhosis. ALT is often measured in conjunction with aspartate aminotransferase (AST) to determine whether the source of the AST is the liver or the heart.

TEST DESCRIPTION:
Alpha-Fetoprotein (AFP) is a glycoprotein and is one of several tumor markers. AFP is measured In blood using an Immunoassay. AFP is not recommended as a saeening procedure to detect cancer in the general population.

TEST DESCRIPTION:
Anti-A Titer (lsoagglutinin Titer Anti-A Serum) is testing that is performed to determine the level of lsoagglutinins present in an individual with blood type B or 0. This test is not useful for individuals with blood type A or AB.

TEST DESCRIPTION:
Anti-B Titer (lsoagglutinin Titer Anti-B Serum) is testing that is performed to determine the level of lsoagglutinins present in an individual with blood type A or 0. This test is not useful for individuals with blood type B or AB.

TEST DESCRIPTION:
Anti-Mullerian Hormone AssessR™ is performed using chemiluminescence. Anti-Mullerian hormone (MH)/Mullerian-inhibiting substance (MIS) may be used in the investigation of ovarian reserve and the premenopausal transition in women; the detection and onset of puberty in the young; the differential diagnosis of intersex disorders; the diagnosis of cryptorchidism and anorchidism, and the evaluation of male gonadal function in all ages.

TEST DESCRIPTION:
Asparate Aminotransferase (AST) is a test performed using spectrophotometry to measure the amount of AST found in the liver, heart, skeletal muscle, kidneys, brain, and red blood cells; it is commonly measured clinically as a marker for liver health. AST is widely distributed throughout the tissues with significant amounts being in the heart and liver. Lesser amounts are found in skeletal muscles, kidneys, pancreas, spleen, lungs, and brain.

TEST DESCRIPTION:
Chagas Radioimmunopreclpitatlon Assay (RIPA) is a supplemental test for the detection of Trypanosoma cruzl infection in Individuals with reactive results on Chagas Disease (T. cruZJ) screen.

TEST DESCRIPTION:
The Transcription-Mediated Amplification (TMA) test is Intended to be used as the primary screening test for the diagnosis of infection with Chlamydia trachomatis or Neisseria gonorrhoeae. Screening for these tests is required for all potential semen or egg donors for in vitro fertilization or other reproductive procedures. Reactive results may be sufficient to consider a donor ineligible.

TEST DESCRIPTION:
The Coccidioides Antibody test is performed for detection of antibodies to Coccidioides, the causative agent of Coccidioidomycosis. Complement Fixation (CF) test is an immunological test that can be used to detect the presence of either specific antibody or specific antigen in a patient’s serum. lmmunodiffusion (ID) is a diagnostic test.

TEST DESCRIPTION:
Cryptococcus Antigen Detection test is performed to detect the presence of capsular polysaccharide antigens of Cryptococcus neoformans in serum.

TEST DESCRIPTION:
Cystic Fibrosis Screen is performed using an Oligonucleotide Ligation Assay Polymerase Chain Reaction (PCR) and will identify approximately 90% of Cystic Fibrosis (CF) mutations in the Caucasian population and 97% in the Ashkenazi Jewish population.

TEST DESCRIPTION:
Cytomegalovirus DNA testing uses Real-Time Polymerase Chain Reaction (PCR) for detection of Cytomegalovirus (CMV) with qualitative results.

TEST DESCRIPTION:
Cytomegalovirus DNA testing uses Real-Time Polymerase Chain Reaction (PCR) for detection of Cytomegalovirus (CMV) with quantitative results.

TEST DESCRIPTION:
A Hematocrit test is a blood test that measures the percentage of the volume of whole blood that is made up of red blood cells.

TEST DESCRIPTION:
A Hepatitis A lgM Antibody test is used in screening early detection of infection. Hepatitis A lgM is the first antibody produced by the body when It Is exposed to Hepatitis A Virus (HAV).

TEST DESCRIPTION:
Hepatitis A Total Antibody Screening is performed using an immunoassay that detects the presence of antibody to Hepatitis A Virus (HAV).

TEST DESCRIPTION:
Hepatitis B Virus lgM Antibody Screening is performed using an Enzyme Immunoassay (EIA) for the qualitative detection of lgM antibody to Hepatitis B Virus (HBV).

TEST DESCRIPTION:
Hepatitis B Virus (HBV) DNA Is a qualitative test useful in assessing potential infectivity of problematic cases of donated blood units and for assessing whether asymptomatic chronic carriers of Hepatitis Bare contagious. It Is performed using Real-Time Polymerase Chain Reaction (PCR). The level of HBV DNA In serum or plasma Is thought to reflect more accurately the replicative state of HBV.

TEST DESCRIPTION:
Hepatitis B Virus (HBV) DNA is a quantitative test for chronic carriers who persist to produce detectable HBV. It is performed using Real-Time Polymerase Chain Reaction (PCR). Patients with chronic liver disease of unknown origin most commonly have HBV that is detected by viral DNA testing. Quantitative measurement of HBV viral DNA may be used to monitor progression of disease.

TEST DESCRIPTION:
Hepatitis Be Antibody (Anti-HBe) test is performed using an immunoassay that determines Anti­ HBe in the blood following exposure to the Hepatitis B Virus (HBV).

TEST DESCRIPTION:
Hepatitis Be Antigen (HBeAg) test is performed using an immunoassay that determines HBeAg which indicates active HBV replication. lnfectivity is evaluated based on HB g and Hepatitis B surface Antigen (HBsAg).

TEST DESCRIPTION:
Hepatitis C Viral (HCV) RNA, Genotype, LIPA testing is performed using a multi-probe reverse hybridization. The HCV line probe assay (LiPA) is used in the analysis process. Hepatitis C genotype is a predictor of response to interferon alfa-2b and to combination therapy with interferon and ribavirin.

TEST DESCRIPTION:
Hepatitis C Viral (HCV) RNA, Quantitative, Real-Time PCR test is performed using quantitative Real-Time Polymerase Chain Reaction (PCR) and is useful in monitoring therapy and disease progression. Reportable range Is 43 to 69,000,000 IU/ml.

TEST DESCRIPTION:
Herpes Simplex Virus (HSV) Antibody Test (lgM) is performed using an Indirect Fluorescent Antibody (IFA) method for detection of lgM antibodies to HSV.

TEST DESCRIPTION:
Herpesvirus 6 Antibodies (lgG, lgM) test is performed using an indirect immunofluorescence assay (IFA). Human herpesvirus 6 (HHV-6) infects peripheral blood leukocytes and is considered the causative agent of roseola. IFAs are used for serological detection of HHV-6.

TEST DESCRIPTION:
Histoplasma Antibody is detected by lmmunodiffusion from serum. Positive immunodiffuslon reactions involve one or more specific precipitin bands. Of these bands, the first to appear in active histoplasmosis is the “M” band. The “M” band Is seen in approximately 70% of proven cases. The •H• band is usually seen in active and progressive histoplasmosis and almost always in the presence of the “M” band, although it is found much less often.

TEST DESCRIPTION:
Histoplasma (H) Total Antibody Is detected by an Enzyme-linked lmmunosorbent assay (ELISA) that measures total antibodies to Histop/asma capsu/atum with approximately 90% sensitivity and 85% specificity compared to immunodiffusion (ID). Samples exhibiting equivocal or positive results are confirmed by Hlstoplasma ID.

TEST DESCRIPTION:
HIV-2 antibody-specific enzyme immunoassay (EIA) detects the presence of Human Immunodeficiency Virus Type 2 (HIV-2). Confirmatory testing can be performed by HIV-2 antibody-specific immunoblot assay.

TEST DESCRIPTION:
HIV-2 lgG Antibodies Western Blot test is performed using an immunoblot assay. This test is intended for use as an additional and more specific test for Human Immunodeficiency Virus Type 2 (HIV-2) antibodies in serum or plasma specimens that have been found to be repeatedly reactive using screening procedures such as enzyme immunoassay (EIA).

TEST DESCRIPTION:
HTLV 1/11 Antibody, Confirmatory Assay is a test performed by line immunoassay (LIA). Human T­ Cell Lymphotropic Virus Type I (HTLV-I) is associated with adult T-cell lymphoblastic leukemia and B-cell chronic lymphocytic leukemia. LIA is used for confirmation of antibody testing.

TEST DESCRIPTION:
HTLV 1/11 Antibody, Supplemental Assay is a test performed by lmmunoblot. Human T-Cell Lymphotropic Virus Type I (HTLV-I) is associated with adult T-cell lymphoblastic leukemia and B­ een chronic lymphocytic leukemia. The lmmunoblot is used as a supplemental (additional, more specific) test for human serum and plasma samples with repeatedly reactive results by an FDA licensed HTLV-1/11 donor screening test..

TEST DESCRIPTION:
HTLV 1/11 DNA, Qualitative Real-Time PCR is a highly specific and sensitive method used to detect Human T-lymphotropic Virus Type I/Type II (HTLV-I/11) proviral DNA in clinical specimens. In addition, the assay can differentiate between HTLV-I and HTLV-11 infected samples.

TEST DESCRIPTION:
Human chorionic gonadotropin (hCG), Total is performed using a qualitative Immunoassay test used to check for the hormone hCG in blood or urine to determine pregnancy.

TEST DESCRIPTION:
IL-28B is a Real-Time Polymerase Chain Reaction (PCR) test that detects the inter1eukin-28B (IL- 28B) gene. The IL-28B gene is involved in the immune response to certain viruses, including Hepatitis C Virus (HCV). The C polymorphism in rs12979860 is strongly associated with a two-fold greater sustained vlrologla!I response in European, African American and Hispanic populations. Knowledge of the host genotype of patients infected with HCV will aid in the clinical decision to initiate treatment with PeglFN and ribavirin (RBV).

TEST DESCRIPTION:
Malaria Screen test is a microscopic examination using a Glemsa stain. Testing is performed to help diagnose malaria, to monitor for relapses, and to determine drug susceptibility of the parasite causing the infection. The identification of malarial parasites and other blood parasites is used to determine treatment and prognosis. Babesia and other ood parasites are noted and reported. Microfilarla can be detected from a Giemsa stain. However, this test Is not recommended for the detection of mlcrofilaria.

TEST DESCRIPTION:
Neutrophil antibody has been observed with neonatal alloimmune neutropenia, autoimmune neutropenla, transfusion reactions and drug-Induced neutropenia. Neutrophil antibody can be detected by Flow Cytometry.

TEST DESCRIPTION:
Serum Protein Electrophoresis (SPEP) measures specific proteins in the blood to help identify some diseases by using spectrophotometry and electrophoresis.

TEST DESCRIPTION:
Strongyloides lgG Antibody is a serodiagnosis by ELISA testing which provides an increased sensitivity diagnostic offering. Strongy/oides stercora/is is a parasitic nematode found in tropical and subtropical regions. Because of low larval densities in feces, stool examination is a relatively insensitive diagnostic test. Significant cross-reactivity may be observed in filarial and other nematode infections.

TEST DESCRIPTION:
The Total Protein test measures the total amount of two classes of proteins found in the fluid portion of blood, albumin and globulin, using spectrophotometry. Total protein is useful in evaluating patients for nutritional status, liver disease, protein-losing renal and gastrointestinal diseases, and many other medical conditions.

TEST DESCRIPTION:
Toxoplasma Antibody (lgG, lgM) testing Is performed using an Immunoassay. Persons should be initially tested for the presence of Toxoplasma-specific lgG antibodies to determine their immune status. A positive lgG titer indicates infection with the organism at some time. If more precise knowledge of the time of infection is necessary, then an lgG positive person should have an lgM test performed by a procedure with minimal nonspecific reactions. Toxoplasmosis is a parasitic infection caused by the protozoan, Toxoplasma gondii.

TEST DESCRIPTION:
Toxoplasma Antibody (lgG) testing is performed using an immunoassay. Persons should be initially tested for the presence of Toxoplasma-speclfic lgG antibodies to determine their immune status. A positive lgG titer indicates Infection with the organism at some time. Toxoplasmosis is a parasitic infection caused by the protozoan, Toxop/asma gondii.

TEST DESCRIPTION:
Toxoplasma Antibody (lgM) testing is performed using an immunoassay. If more precise knowledge of the time of infection is necessary, then an lgG positive person should have an lgM test performed by a procedure with minimal nonspecific reactions. Toxoplasmosis is a parasitic infection caused by the protozoan, Toxoplasma gondii.

TEST DESCRIPTION:
Varicella-Zoster Virus Antibody (lgG / lgM) testing is· performed using an immunoassay. lgG is useful In determining post-vaccination status. A single positive test result suggests recent or current Infection. A second sample should be submitted for parallel testing in all patients with equivocal results. Varicella-Zoster Virus (Vl)/) causes chicken pox and when reactivated, potentially decades later, causes shingles. Twenty percent of adults will develop shingles, a rash or blister of the skin that may cause severe pain.·